|
Patients
|
135
|
|
Women
|
47 (35)
|
|
Mean age in years (SD)
|
64 (9)
|
|
Education
| |
|
Lowa
|
34 (25)
|
|
Middleb
|
53 (39)
|
|
Highc
|
39 (29)
|
|
Other
|
9 (7)
|
|
Number of prescribed oral glucose-lowering drugsd
| |
|
1 oral glucose-lowering drug
|
91 (68)
|
|
2 oral glucose-lowering drugs
|
38 (29)
|
|
3 oral glucose-lowering drugs
|
4 (3)
|
|
Classes of prescribed oral glucose-lowering drugsd
| |
|
Biguanides
|
125 (94)
|
|
Dipeptidyl peptidase 4 (DPP-4) inhibitors
|
4 (3)
|
|
Glucagon-like peptide-1 (GLP-1)
|
5 (4)
|
|
Sulfonamides
|
42 (32)
|
|
Thiazolidinediones
|
3 (2)
|
|
Median number of systemic drugs prescribed (IQR)
|
7 (5–9)
|
|
Patients additionally on insulin
|
24 (18)
|
|
Patients reporting an ADE
|
37 (27)
|
|
Number of ADEs reported (range)
|
146 (1–11)
|
|
First time experiencing the ADE
| |
|
Today
|
6 (4)
|
|
Yesterday
|
1 (1)
|
|
2-7 days ago
|
5 (3)
|
|
Between 1 week and 1 month ago
|
14 (10)
|
|
Between 1 and 6 months ago
|
14 (10)
|
|
Between 6 and 12 months ago
|
21 (14)
|
|
More than 12 months ago
|
85 (58)
|
|
ADE gone away or improved
| |
|
Not yet
|
120 (82)
|
|
Clearly improved
|
14 (10)
|
|
ADE was treated and has improved
|
4 (3)
|
|
ADE went away by itself
|
0 (0)
|
|
ADE went away after quitting medication
|
1 (1)
|
|
ADE went away after treatment
|
1 (1)
|
|
Other
|
6 (4)
|
|
How much bothersome
| |
|
Not at all
|
11 (8)
|
|
Only a bit
|
22 (15)
|
|
Somewhat
|
71 (49)
|
|
Quite a lot
|
31 (21)
|
|
Very much
|
11 (8)
|
|
Influence daily functioning
| |
|
None
|
47 (32)
|
|
Only a bit
|
24 (17)
|
|
Somewhat
|
54 (37)
|
|
Quite a lot
|
18 (12)
|
|
Very much
|
2 (1)
|
